5Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009 [ J ]. CA Cancer J Clin,2009,59(4) :225-249.
6Li D, Xie K, Wolff R, et al. Pancreatic cancer [ J ]. Lancet, 2004, 363 (9414) : 1049-1057.
7Banu E, Banu A, Fodor A, et al. Meta-analysis pf randomized trials comparing gemcitabine-based doublets versus gemcitabine alone in patients with advanced and metastatic pancreatic cancer[ J ]. Drugs Aging,2007,24(10) :857-879.
8Burris H, Moore M J, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:a randomized trial[ J ]. J Clin Oncol, 1997,15 (6) :2403-2413.
9Loehrer PJ, Powell ME, Cardenes HR, et al. A randomized phase Ⅲ study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with localized, unresectable pancreatic cancer: E4201 [ J]. J Clin Oncol, 2008, 26 (Suppl 15 ) :4506.
10Heinemann V, Boeck S, Hinke A, et al. Meta-analysis of randomized trials : evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer[ J ]. BMC Cancer,2008,8( 1 ) :82.
